7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 
      
    		                          
      cash flows from operating activities:
    		                          
      net income
    		-45,083,000 -47,190,000 -49,581,000 -48,562,000 -49,609,000 -45,935,000 -43,043,000 -43,061,000 -46,892,000 -88,395,000 -79,838,000 -70,433,000 -61,298,000 -62,740,000 -63,701,000 -67,241,000 -72,807,000 -67,216,000 -56,196,000 -21,460,000 -47,384,000 -32,299,000 -24,435,000 -21,690,000 -21,430,000 -19,912,000 
      adjustments to reconcile net income to net cash flows used in operating activities:
    		                          
      stock-based compensation expense
    		10,174,000 14,073,000 11,160,000 12,856,000 12,514,000 12,313,000 12,373,000 12,988,000 14,268,000 10,794,000 11,794,000 12,371,000 11,119,000 9,706,000 9,828,000 10,609,000 6,994,000 5,345,000 4,729,000 4,107,000 6,229,000 2,805,000 2,614,000    
      depreciation expense
    		450,000 456,000 465,000 571,000 608,000 601,000 742,000 820,000 783,000 780,000 759,000 743,000 732,000 695,000 666,000 484,000 460,000          
      noncash lease expense
    		1,147,000 1,136,000 1,124,000 1,113,000 1,102,000 1,091,000 1,081,000 1,000,000 954,000 919,000 852,000 842,000 833,000 886,000 886,000            
      net amortization of (discounts) premium on marketable securities
    		-1,653,000   -1,953,000 -1,566,000                      
      changes in operating assets and liabilities:
    		                          
      accounts receivable
    		-878,000 -4,167,000 -4,489,000 -766,000 77,000 1,230,000 2,383,000 -2,836,000 -2,561,000 -2,546,000 559,000 3,213,000 -7,925,000 -2,082,000 -4,430,000            
      inventory
    		-918,000 972,000 3,531,000 -3,631,000 -1,258,000 -3,363,000 3,165,000 -1,443,000 -5,468,000 -6,880,000 881,000 -6,129,000 1,973,000 -786,000 -1,657,000            
      prepaid expenses and other current assets
    		-1,967,000 2,171,000 3,901,000 1,797,000 -4,061,000 -11,544,000 4,026,000 -148,000 -1,844,000 -2,694,000 -2,751,000 568,000 -3,057,000 -2,802,000 1,176,000 -1,999,000 1,853,000 -9,894,000 -1,690,000 -1,907,000 3,170,000 -2,539,000 -2,438,000 -980,000 187,000 -832,000 
      other long-term assets
    		140,000 -4,935,000 0   -1,000 -7,000                    
      accounts payable
    		-6,944,000 4,933,000 3,272,000 -1,421,000 993,000 5,569,000 -3,386,000 -1,549,000 4,685,000 -345,000 -533,000 2,144,000 -433,000 2,375,000 -2,852,000 1,455,000 -8,511,000 4,400,000 870,000 2,963,000 2,629,000 2,257,000 -491,000 1,083,000 1,142,000 1,465,000 
      accrued expenses and other current liabilities
    		-8,196,000 5,992,000 3,649,000 2,234,000 -7,464,000 5,829,000 3,199,000 -10,382,000 -14,830,000 21,462,000 10,359,000 4,848,000 -9,384,000 5,584,000 10,775,000 4,364,000 -6,800,000 12,151,000 4,799,000 4,602,000 2,637,000 2,640,000 -435,000    
      operating lease liabilities
    		-857,000 -829,000 -813,000 -803,000 -791,000 -763,000 -749,000 -720,000 -702,000 -661,000 -626,000 -616,000 -607,000 -203,000 -185,000 -390,000 -555,000 127,000 -97,000 -201,000 -148,000      
      net cash flows used in operating activities
    		-54,585,000 -28,809,000 -29,807,000 -38,626,000 -49,455,000 -35,158,000 -20,828,000 -45,524,000 -51,352,000 -67,176,000 -53,999,000 -51,967,000 -67,682,000 -49,128,000 -49,341,000 -60,844,000 -80,370,000 -55,833,000         
      cash flows from investing activities:
    		                          
      purchases of marketable securities
    		-20,264,000 -59,657,000 -33,780,000 -106,275,000 -122,860,000 -82,175,000 -58,707,000   -21,657,000 -101,597,000 -180,296,000 -31,825,000 -127,764,000 -150,823,000 -614,655,000 -203,527,000 -198,952,000 -364,431,000 -74,152,000 -179,607,000      
      maturities of marketable securities
    		83,041,000 61,919,000 75,245,000 110,929,000 87,021,000 98,460,000 53,209,000 77,978,000 59,652,000 108,511,000 99,464,000 104,242,000 156,370,000 175,250,000 129,400,000 120,143,000 203,120,000          
      sales of marketable securities
    		 0 0 0 785,000     10,996,000 22,584,000   0 24,470,000            
      purchases of property and equipment
    		-146,000 -63,000 -62,000 -293,000 -360,000 19,000 -573,000   1,109,000 -2,010,000 -432,000 -637,000 -430,000 -1,233,000 -2,984,000 -669,000 -1,725,000 -2,966,000 -203,000 -41,000 -303,000 -216,000 -455,000 -151,000 -130,000 
      net cash flows from investing activities
    		62,631,000 2,199,000   -35,414,000 16,304,000 -6,071,000 -104,194,000 59,652,000 98,952,000 14,441,000 -60,453,000 123,908,000              
      cash flows from financing activities:
    		                          
      proceeds from offerings of common stock, net of underwriting discounts and commissions
    		 0 14,622,000 0 135,125,000     1,000 0 0 8,588,000              
      proceeds from pre-funded warrant exercise
    		9,000  0 0 24,000  6,000                    
      payments of offering costs
    		  0 0 -634,000  0    0                
      proceeds from stock option exercises and employee stock purchase plan
    		513,000 890,000 968,000 838,000 171,000 478,000 203,000 868,000 83,000 1,977,000 1,706,000                
      net cash flows from financing activities
    		522,000 890,000 15,590,000 838,000 134,686,000 478,000 209,000 164,224,000 83,000 1,978,000 1,706,000 1,682,000 9,524,000 27,792,000 3,228,000 4,389,000 191,392,000 761,000         
      net increase in cash and cash equivalents
    		8,568,000 -25,720,000 27,186,000 -33,427,000 49,817,000   14,506,000 8,383,000   -110,738,000 65,750,000 24,743,000 -44,292,000 -74,206,000 109,332,000 -53,392,000 116,475,000   -27,111,000 -25,652,000   114,605,000 
      effect of exchange rate changes on cash and cash equivalents
    		-847,000 1,140,000 -493,000 184,000 79,000 579,000 -470,000 -140,000 -114,000 120,000 94,000 37,000 1,000              
      cash and cash equivalents at beginning of period
    		83,507,000 0 0 0 64,741,000 0 0 0 87,063,000 0 0 0 135,897,000 0 0 0 120,320,000 0 0 0 293,764,000 0 0 0 196,754,000 0 
      cash and cash equivalents at end of period
    		91,228,000 -24,580,000 26,693,000 -33,243,000 114,637,000 -17,797,000 -27,160,000 14,366,000 95,332,000 33,874,000 -37,758,000 -110,701,000 201,648,000 24,743,000 -44,292,000 -74,206,000 229,652,000 -53,392,000 116,475,000 -24,991,000 82,228,000 -27,111,000 -25,652,000 166,654,000 179,873,000 114,605,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                          
      acquired in-process research and development
    		         0                 
      net amortization (accretion) of premiums (discounts) on marketable securities
    		                          
      income tax liabilities
    		                          
      increase in restricted investments
    		             -977,000 0 -1,000 -614,000 0 0   0 0    
      proceeds from pre-funded warrants
    		                          
      payments of public offering costs
    		             -163,000 0 -300,000 -352,000 -267,000    0     
      net accretion of discounts on marketable securities
    		             239,000 160,000 -478,000 -1,532,000 -1,729,000 -973,000 -811,000 -486,000      
      net cash flows used in investing activities
    		              1,821,000 -17,751,000 -1,690,000 1,680,000         
      gain on disposal of equipment
    		                          
      proceeds from sale of equipment
    		             0             
      proceeds from offerings of common stock and pre-funded warrants, net of underwriting discounts and commissions
    		      0                    
      net decrease in cash and cash equivalents
    		                    -211,536,000    -16,881,000  
      net amortization (accretion) of premium (discounts) on marketable securities
    		       -33,000 255,000  545,000 482,000 365,000              
      other long-term liabilities
    		                 13,000 102,000 135,000 100,000 169,000 165,000 39,000 -5,000 -5,000 
      repayment of notes payable to related party
    		                 -1,154,000 -47,000 -62,000 -31,000 -47,000 -47,000 -47,000 -46,000 -47,000 
      supplemental disclosure of cash flow information:
    		                          
      cash paid for interest
    		                 12,000 17,000 25,000 13,000 20,000 21,000 21,000 22,000 23,000 
      addition of operating lease asset included in accrued expenses and other current liabilities
    		                          
      supplemental disclosure of non-cash investing and financing activities:
    		                          
      purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities
    		                          
      unsettled exercise of stock options
    		                          
      (gain) loss on disposal of equipment
    		                          
      operating lease liabilities arising from obtaining operating lease assets
    		                          
      proceeds from exercise of stock options
    		            936,000  3,228,000 4,827,000 2,569,000 2,182,000 2,476,000 81,000 1,149,000 107,000 91,000 707,000 10,000  
      proceeds from public offerings, net of underwriting discounts and commissions
    		             18,194,000 0 -138,000 189,175,000 0         
      amounts capitalized under build-to-suit lease transaction
    		                     -5,989,000 846,000    
      property and equipment purchases included in accounts payable and accrued expenses and other current liabilities
    		              -209,000 373,000 152,000          
      offering costs included in accounts payable and accrued expenses and other current liabilities
    		                438,000          
      unbilled receivables
    		                          
      inventory purchases included in accrued expenses and other current liabilities
    		                          
      operating lease assets
    		                528,000 525,000         
      loss on disposal of property and equipment
    		                         0 
      proceeds from issuance of convertible preferred shares
    		                         0 
      payments of convertible preferred share issuance costs
    		                         0 
      retirement of assets
    		                          
      conversion of convertible preferred shares into common stock
    		                          
      depreciation and amortization expense
    		                  169,000 112,000 104,000 99,000 88,000 74,000 56,000 49,000 
      maturities and sales of marketable securities
    		                  72,587,000        
      amounts capitalized under build-to-suit lease transactions
    		                          
      property and equipment purchases included in accrued expenses and other current liabilities
    		                          
      offering costs included in accrued expenses and other current liabilities
    		                          
      unbilled receivable
    		                          
      operating lease, right-of-use assets
    		                   194,000 143,000      
      net cash from operating activities
    		                   -37,266,000 -33,006,000 -26,868,000 -24,932,000 -18,289,000 -16,694,000 -12,753,000 
      capex
    		                   -203,000 -41,000 -303,000 -216,000 -455,000 -54,000 -130,000 
      free cash flows
    		                   -37,469,000 -33,047,000 -27,171,000 -25,148,000 -18,744,000 -16,748,000 -12,883,000 
      net cash from investing activities
    		                   12,256,000 -179,648,000 -303,000 -216,000 -1,524,000 -151,000 -130,000 
      net cash from financing activities
    		                   19,000 1,118,000 60,000 -504,000   127,488,000 
      supplemental disclosure of non-cash investing activities:
    		                          
      supplemental disclosure of non-cash financing activities:
    		                          
      offering costs included in accounts payable and accrued expenses
    		                          
      purchases of property and equipment included in accounts payable and accrued expenses
    		                          
      other assets
    		                          
      proceeds from follow-on public offering, net of underwriting discounts and commissions
    		                      1,000    
      purchases of property and equipment included in accounts payable
    		                        97,000  
      offering costs included in accounts payable or accrued expenses
    		                          
      payments of follow-on public offering costs
    		                          
      payments of initial public offering costs
    		                         -1,577,000 
      share-based compensation expense
    		                        2,037,000 2,844,000 
      accrued expenses
    		                        1,319,000 3,638,000 
      net cash used by financing activities
    		                        -36,000  
      deferred offering costs included in accounts payable or accrued expenses
    		                          
      non-cash interest expense
    		                          
      proceeds from initial public offering, net of underwriting discounts and commissions
    		                          
      proceeds from issuance of convertible notes payable to related parties
    		                          
      conversion of notes payable and accrued interest into convertible preferred shares
    		                          
      conversion of member units into series a convertible preferred shares
    		                          
      gain on extinguishment of notes payable to related party
    		                          
      purchases of property and equipment included in accounts payable or accrued expenses
    		                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.